Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Perrigo Co Plc (PRGO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Perrigo Co Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1585364.
Total stock buying since 2015: $38,893,140.
Total stock sales since 2015: $25,496,495.
Total stock option exercises since 2015: $58,222,503.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 16,823 | $399,196 | 7,800 | $214,032 | 179,729 | $4,775,127 |
| 2024 | 20,906 | $553,771 | 74,535 | $2,089,022 | 166,664 | $4,822,675 |
| 2023 | 41,490 | $1,314,519 | 214,869 | $7,686,349 | 194,964 | $7,015,628 |
| 2022 | 0 | $0 | 33,066 | $1,214,496 | 172,736 | $6,506,164 |
| 2021 | 64,968 | $2,432,603 | 2,662 | $109,767 | 123,099 | $4,955,734 |
| 2020 | 11,465 | $545,920 | 4,595 | $238,943 | 104,443 | $5,542,792 |
| 2019 | 4,000 | $187,892 | 7,600 | $387,546 | 97,675 | $4,766,460 |
| 2018 | 443,983 | $33,177,304 | 0 | $0 | 54,995 | $3,947,332 |
| 2017 | 700 | $60,060 | 9,907 | $843,613 | 30,445 | $2,345,890 |
| 2016 | 2,500 | $221,875 | 52,667 | $6,482,088 | 72,072 | $4,921,395 |
| 2015 | 0 | $0 | 36,046 | $6,230,639 | 66,728 | $8,623,306 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 13,323 | $304,346 | 0 | $0 | 0 | $0 |
| 2025-07 | 0 | $0 | 0 | $0 | 28,326 | $772,450 |
| 2025-06 | 0 | $0 | 0 | $0 | 15,399 | $402,836 |
| 2025-05 | 3,500 | $94,850 | 0 | $0 | 81,708 | $2,125,224 |
| 2025-04 | 0 | $0 | 0 | $0 | 34,715 | $913,349 |
| 2025-03 | 0 | $0 | 7,800 | $214,032 | 19,581 | $561,268 |
| 2024-12 | 0 | $0 | 17,598 | $497,495 | 0 | $0 |
| 2024-10 | 0 | $0 | 0 | $0 | 3,611 | $90,022 |
| 2024-09 | 0 | $0 | 8,954 | $244,444 | 0 | $0 |
| 2024-08 | 0 | $0 | 47,983 | $1,347,083 | 0 | $0 |
| 2024-07 | 0 | $0 | 0 | $0 | 29,246 | $792,996 |
| 2024-06 | 0 | $0 | 0 | $0 | 4,532 | $122,092 |
| 2024-05 | 1,000 | $27,900 | 0 | $0 | 81,067 | $2,449,844 |
| 2024-03 | 2,861 | $77,634 | 0 | $0 | 48,208 | $1,367,721 |
| 2024-02 | 17,045 | $448,237 | 0 | $0 | 0 | $0 |
| 2023-11 | 23,590 | $696,706 | 0 | $0 | 0 | $0 |
| 2023-10 | 0 | $0 | 0 | $0 | 738 | $22,479 |
| 2023-08 | 0 | $0 | 0 | $0 | 5,478 | $212,984 |
| 2023-07 | 0 | $0 | 0 | $0 | 13,329 | $434,924 |
| 2023-06 | 10,000 | $330,640 | 0 | $0 | 4,532 | $152,819 |
| 2023-05 | 2,900 | $96,903 | 197,646 | $7,066,437 | 64,169 | $2,108,592 |
| 2023-03 | 5,000 | $190,270 | 17,223 | $619,912 | 106,718 | $4,083,830 |
| 2022-12 | 0 | $0 | 2,368 | $74,947 | 0 | $0 |
| 2022-10 | 0 | $0 | 0 | $0 | 739 | $28,148 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-22 | Willis Robert (EVP & CHRO) | Buy | 1,488 | 24.10 | 35,857 |
| 2025-08-18 | Bezerra Eduardo Guarita (EVP & Chief Financial Officer) | Buy | 3,000 | 22.74 | 68,208 |
| 2025-08-18 | Parker Geoffrey M. (Director) | Buy | 4,375 | 22.97 | 100,498 |
| 2025-08-08 | Lockwood-taylor Patrick (CEO) | Buy | 4,460 | 22.37 | 99,783 |
| 2025-07-10 | Lockwood-taylor Patrick (CEO) | Option Ex | 28,326 | 27.27 | 772,450 |
| 2025-06-06 | Khoury Roberto (EVP and President of CSCI) | Option Ex | 10,868 | 26.16 | 284,306 |
| 2025-06-06 | Bezerra Eduardo Guarita (EVP & Chief Financial Officer) | Option Ex | 4,531 | 26.16 | 118,530 |
| 2025-05-14 | Brown Julia M (Director) | Option Ex | 9,904 | 26.01 | 257,603 |
| 2025-05-14 | Manzone Albert (Director) | Option Ex | 9,904 | 26.01 | 257,603 |
| 2025-05-14 | O'connor Donal (Director) | Option Ex | 9,904 | 26.01 | 257,603 |
| 2025-05-14 | Karaboutis Adriana (Director) | Option Ex | 9,904 | 26.01 | 257,603 |
| 2025-05-14 | Parker Geoffrey M. (Director) | Option Ex | 9,904 | 26.01 | 257,603 |
| 2025-05-14 | Alford Bradley A (Director) | Option Ex | 9,904 | 26.01 | 257,603 |
| 2025-05-14 | Ashford Orlando D (Director) | Option Ex | 12,380 | 26.01 | 322,003 |
| 2025-05-14 | Kindler Jeffrey B (Director) | Option Ex | 9,904 | 26.01 | 257,603 |
| 2025-05-12 | Parker Geoffrey M. (Director) | Buy | 3,500 | 27.10 | 94,850 |
| 2025-04-04 | Lockwood-taylor Patrick (CEO) | Option Ex | 17,835 | 26.31 | 469,238 |
| 2025-04-04 | Willis Robert (EVP & CHRO) | Option Ex | 2,070 | 26.31 | 54,461 |
| 2025-04-04 | Bezerra Eduardo Guarita (EVP & Chief Financial Officer) | Option Ex | 6,370 | 26.31 | 167,594 |
| 2025-04-04 | Schmelter Triona (EVP & President CSCA) | Option Ex | 5,733 | 26.31 | 150,835 |
| 2025-04-04 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 2,707 | 26.31 | 71,221 |
| 2025-03-10 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Sale | 7,800 | 27.44 | 214,032 |
| 2025-03-07 | Willis Robert (EVP & CHRO) | Option Ex | 2,163 | 27.76 | 60,044 |
| 2025-03-07 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 2,941 | 27.76 | 81,642 |
| 2025-03-06 | Willis Robert (EVP & CHRO) | Option Ex | 1,759 | 28.68 | 50,448 |
| 2025-03-06 | Bezerra Eduardo Guarita (EVP & Chief Financial Officer) | Option Ex | 4,870 | 28.68 | 139,671 |
| 2025-03-06 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 2,300 | 28.68 | 65,964 |
| 2025-03-05 | Brown Julia M (Director) | Option Ex | 5,548 | 29.47 | 163,499 |
| 2024-12-09 | Kindler Jeffrey B (Director) | Sale | 17,598 | 28.27 | 497,495 |
| 2024-10-04 | Schmelter Triona (EVP & President CSCA) | Option Ex | 3,611 | 24.93 | 90,022 |
| 2024-09-13 | Doyle Katherine C. (Director) | Sale | 8,954 | 27.30 | 244,444 |
| 2024-08-26 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Sale | 13,000 | 29.40 | 382,252 |
| 2024-08-20 | Andersen Svend (EVP & President CHCI) | Sale | 34,983 | 27.58 | 964,831 |
| 2024-07-10 | Lockwood-taylor Patrick (CEO) | Option Ex | 28,326 | 27.16 | 769,334 |
| 2024-07-08 | Ives Alison (EVP & Chief Scientific Officer) | Option Ex | 920 | 25.72 | 23,662 |
| 2024-06-07 | Bezerra Eduardo Guarita (EVP & Chief Financial Officer) | Option Ex | 4,532 | 26.94 | 122,092 |
| 2024-05-28 | Andersen Svend (EVP & President CHCI) | Buy | 1,000 | 27.90 | 27,900 |
| 2024-05-15 | Manzone Albert (Director) | Option Ex | 8,764 | 30.22 | 264,848 |
| 2024-05-15 | Mann Erica L (Director) | Option Ex | 8,764 | 30.22 | 264,848 |
| 2024-05-15 | O'connor Donal (Director) | Option Ex | 8,764 | 30.22 | 264,848 |
| 2024-05-15 | Karaboutis Adriana (Director) | Option Ex | 8,764 | 30.22 | 264,848 |
| 2024-05-15 | Doyle Katherine C. (Director) | Option Ex | 8,764 | 30.22 | 264,848 |
| 2024-05-15 | Parker Geoffrey M. (Director) | Option Ex | 8,764 | 30.22 | 264,848 |
| 2024-05-15 | Alford Bradley A (Director) | Option Ex | 8,764 | 30.22 | 264,848 |
| 2024-05-15 | Ashford Orlando D (Director) | Option Ex | 10,955 | 30.22 | 331,060 |
| 2024-05-15 | Kindler Jeffrey B (Director) | Option Ex | 8,764 | 30.22 | 264,848 |
| 2024-03-07 | Ives Alison (EVP & Chief Scientific Officer) | Option Ex | 1,746 | 29.69 | 51,838 |
| 2024-03-07 | Willis Robert (EVP & CHRO) | Option Ex | 2,163 | 29.69 | 64,219 |
| 2024-03-07 | Andersen Svend (EVP & President CHCI) | Option Ex | 5,468 | 29.69 | 162,344 |
| 2024-03-07 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 2,942 | 29.69 | 87,347 |
| 2024-03-07 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 2,249 | 29.69 | 66,772 |
| 2024-03-06 | Ives Alison (EVP & Chief Scientific Officer) | Option Ex | 2,030 | 28.09 | 57,022 |
| 2024-03-06 | Willis Robert (EVP & CHRO) | Option Ex | 1,759 | 28.09 | 49,410 |
| 2024-03-06 | Bezerra Eduardo Guarita (EVP & Chief Financial Officer) | Option Ex | 4,870 | 28.09 | 136,798 |
| 2024-03-06 | Andersen Svend (EVP & President CHCI) | Option Ex | 3,788 | 28.09 | 106,404 |
| 2024-03-06 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 2,300 | 28.09 | 64,607 |
| 2024-03-06 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 1,759 | 28.09 | 49,410 |
| 2024-03-06 | Farrington Thomas (EVP and CIO) | Option Ex | 1,881 | 28.09 | 52,837 |
| 2024-03-06 | Hanson Kyle (EVP & General Counsel) | Option Ex | 3,518 | 28.09 | 98,820 |
| 2024-03-05 | Ives Alison (EVP & Chief Scientific Officer) | Buy | 2,490 | 27.26 | 67,877 |
| 2024-03-05 | Ives Alison (EVP & Chief Scientific Officer) | Option Ex | 1,698 | 27.26 | 46,287 |
| 2024-03-05 | Willis Robert (EVP & CHRO) | Option Ex | 1,279 | 27.26 | 34,865 |
| 2024-03-05 | Andersen Svend (EVP & President CHCI) | Option Ex | 3,411 | 27.26 | 92,983 |
| 2024-03-05 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 2,071 | 27.26 | 56,455 |
| 2024-03-05 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 1,583 | 27.26 | 43,152 |
| 2024-03-05 | Farrington Thomas (EVP and CIO) | Option Ex | 1,693 | 27.26 | 46,151 |
| 2024-03-01 | Willis Robert (EVP & CHRO) | Buy | 371 | 26.30 | 9,757 |
| 2024-02-29 | Lockwood-taylor Patrick (CEO) | Buy | 9,500 | 26.54 | 252,168 |
| 2024-02-29 | Ives Alison (EVP & Chief Scientific Officer) | Buy | 1,545 | 26.44 | 40,849 |
| 2024-02-29 | Willis Robert (EVP & CHRO) | Buy | 6,000 | 25.87 | 155,220 |
| 2023-11-24 | Willis Robert (EVP & CHRO) | Buy | 5,550 | 31.01 | 172,105 |
| 2023-11-16 | Ives Alison (EVP & Chief Scientific Officer) | Buy | 2,040 | 29.34 | 59,853 |
| 2023-11-14 | Lockwood-taylor Patrick (CEO) | Buy | 11,000 | 28.99 | 318,868 |
| 2023-11-14 | Bezerra Eduardo Guarita (EVP & Chief Financial Officer) | Buy | 5,000 | 29.18 | 145,880 |
| 2023-10-06 | Ives Alison (EVP & Chief Scientific Officer) | Option Ex | 738 | 30.46 | 22,479 |
| 2023-08-15 | Manzone Albert | Option Ex | 5,478 | 38.88 | 212,984 |
| 2023-07-07 | Ives Alison (EVP & Chief Scientific Officer) | Option Ex | 920 | 32.63 | 30,019 |
| 2023-07-07 | Hanson Kyle (EVP & General Counsel) | Option Ex | 12,409 | 32.63 | 404,905 |
| 2023-06-13 | Parker Geoffrey M. | Buy | 10,000 | 33.06 | 330,640 |
| 2023-06-07 | Bezerra Eduardo Guarita (EVP & Chief Financial Officer) | Option Ex | 4,532 | 33.72 | 152,819 |
| 2023-05-23 | Andersen Svend (EVP & President CHCI) | Buy | 2,900 | 33.41 | 96,903 |
| 2023-05-17 | Mann Erica L | Option Ex | 7,778 | 32.86 | 255,585 |
| 2023-05-17 | O'connor Donal | Option Ex | 7,778 | 32.86 | 255,585 |
| 2023-05-17 | Karaboutis Adriana | Option Ex | 7,778 | 32.86 | 255,585 |
| 2023-05-17 | Doyle Katherine C. | Option Ex | 7,778 | 32.86 | 255,585 |
| 2023-05-17 | Parker Geoffrey M. | Option Ex | 7,778 | 32.86 | 255,585 |
| 2023-05-17 | Alford Bradley A | Option Ex | 7,778 | 32.86 | 255,585 |
| 2023-05-17 | Ashford Orlando D | Option Ex | 9,723 | 32.86 | 319,497 |
| 2023-05-17 | Kindler Jeffrey B | Option Ex | 7,778 | 32.86 | 255,585 |
| 2023-05-11 | Kessler Murray S (CEO) | Sale | 197,646 | 35.75 | 7,066,437 |
| 2023-03-13 | Farrington Thomas (EVP and CIO) | Sale | 3,723 | 35.58 | 132,468 |
| 2023-03-10 | Dillard James E Iii (EVP & President CSCA) | Sale | 9,000 | 35.70 | 321,309 |
| 2023-03-08 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Sale | 4,500 | 36.92 | 166,135 |
| 2023-03-07 | Ives Alison (EVP & Chief Scientific Officer) | Option Ex | 1,746 | 37.71 | 65,841 |
| 2023-03-07 | Willis Robert (EVP & CHRO) | Option Ex | 2,163 | 37.71 | 81,566 |
| 2023-03-07 | Andersen Svend (EVP & President CHCI) | Option Ex | 5,468 | 37.71 | 206,198 |
| 2023-03-07 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 2,942 | 37.71 | 110,942 |
| 2023-03-07 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 2,250 | 37.71 | 84,847 |
| 2023-03-07 | Dillard James E Iii (EVP & President CSCA) | Option Ex | 5,537 | 37.71 | 208,800 |
| 2023-03-07 | Farrington Thomas (EVP and CIO) | Option Ex | 2,406 | 37.71 | 90,730 |
| 2023-03-07 | Kessler Murray S (CEO) | Option Ex | 26,994 | 37.71 | 1,017,943 |
| 2023-03-06 | Parker Geoffrey M. | Buy | 5,000 | 38.05 | 190,270 |
| 2023-03-03 | Ives Alison (EVP & Chief Scientific Officer) | Option Ex | 2,208 | 38.75 | 85,560 |
| 2023-03-03 | Willis Robert (EVP & CHRO) | Option Ex | 2,231 | 38.75 | 86,451 |
| 2023-03-03 | Andersen Svend (EVP & President CHCI) | Option Ex | 5,951 | 38.75 | 230,601 |
| 2023-03-03 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 3,613 | 38.75 | 140,003 |
| 2023-03-03 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 2,636 | 38.75 | 102,145 |
| 2023-03-03 | Dillard James E Iii (EVP & President CSCA) | Option Ex | 4,675 | 38.75 | 181,156 |
| 2023-03-03 | Farrington Thomas (EVP and CIO) | Option Ex | 2,954 | 38.75 | 114,467 |
| 2023-03-03 | Kessler Murray S (CEO) | Option Ex | 32,944 | 38.75 | 1,276,580 |
| 2022-12-16 | Quinn Grainne (EVP, Chief Medical Officer) | Sale | 2,368 | 31.65 | 74,947 |
| 2022-10-07 | Ives Alison (EVP & Chief Scientific Officer) | Option Ex | 739 | 38.09 | 28,148 |
| 2022-05-17 | Mann Erica L | Option Ex | 6,599 | 38.57 | 254,523 |
| 2022-05-17 | Samuels Theodore R. Ii | Option Ex | 6,599 | 38.57 | 254,523 |
| 2022-05-17 | O'connor Donal | Option Ex | 6,599 | 38.57 | 254,523 |
| 2022-05-17 | Karaboutis Adriana | Option Ex | 6,599 | 38.57 | 254,523 |
| 2022-05-17 | Doyle Katherine C. | Option Ex | 6,599 | 38.57 | 254,523 |
| 2022-05-17 | Parker Geoffrey M. | Option Ex | 6,599 | 38.57 | 254,523 |
| 2022-05-17 | Alford Bradley A | Option Ex | 6,599 | 38.57 | 254,523 |
| 2022-05-17 | Ashford Orlando D | Option Ex | 6,599 | 38.57 | 254,523 |
| 2022-05-17 | Kindler Jeffrey B | Option Ex | 6,599 | 38.57 | 254,523 |
| 2022-04-05 | Silcock Raymond (EVP, Chief Financial Officer) | Option Ex | 3,963 | 36.27 | 143,738 |
| 2022-03-14 | Farrington Thomas (EVP and CIO) | Sale | 26,744 | 37.18 | 994,315 |
| 2022-03-07 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Sale | 3,954 | 36.73 | 145,234 |
| 2022-03-04 | Willis Robert (EVP & CHRO) | Option Ex | 5,012 | 37.23 | 186,596 |
| 2022-03-04 | Andersen Svend (EVP & President CHCI) | Option Ex | 8,911 | 37.23 | 331,756 |
| 2022-03-04 | Janish Ronald Craig (EVP, Gbl Ops & SC & CTO) | Option Ex | 5,410 | 37.23 | 201,414 |
| 2022-03-04 | Quinn Grainne (EVP, Chief Medical Officer) | Option Ex | 3,862 | 37.23 | 143,782 |
| 2022-03-04 | Dillard James E Iii (EVP & President CSCA) | Option Ex | 7,002 | 37.23 | 260,684 |
| 2022-03-04 | Ashford Orlando D | Option Ex | 2,984 | 37.23 | 111,094 |
| 2022-03-04 | Farrington Thomas (EVP and CIO) | Option Ex | 4,424 | 37.23 | 164,705 |
| 2022-03-04 | Kingma Todd W (Executive VP, General Counsel) | Option Ex | 8,911 | 37.23 | 331,756 |
| 2022-03-04 | Kessler Murray S (CEO) | Option Ex | 49,328 | 37.23 | 1,836,481 |
| 2022-03-04 | Silcock Raymond (EVP, Chief Financial Officer) | Option Ex | 8,502 | 37.23 | 316,529 |
| 2022-02-07 | Dillard James E Iii (EVP & President CSCA) | Option Ex | 4,297 | 36.95 | 158,774 |
| 2021-12-17 | Kingma Todd W (Executive VP, General Counsel) | Buy | 3,000 | 37.55 | 112,647 |
| 2021-12-16 | Parker Geoffrey M. | Buy | 5,000 | 36.85 | 184,270 |
| 2021-12-16 | Alford Bradley A | Buy | 13,000 | 36.88 | 479,414 |
| 2021-12-06 | Andersen Svend (EVP & President CHCI) | Buy | 3,655 | 37.09 | 135,582 |
| 2021-12-03 | Silcock Raymond (EVP, Chief Financial Officer) | Buy | 27,500 | 36.03 | 990,935 |
| 2021-12-02 | Classon Rolf A | Buy | 2,800 | 35.67 | 99,873 |
| 2021-08-12 | Doyle Katherine C. | Option Ex | 5,637 | 41.28 | 232,695 |
| 2021-05-07 | Samuels Theodore R. Ii | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | O'connor Donal | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | Karaboutis Adriana | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | Parker Geoffrey M. | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | Alford Bradley A | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | Kindler Jeffrey B | Option Ex | 5,804 | 42.96 | 249,339 |
| 2021-05-07 | Classon Rolf A | Option Ex | 7,255 | 42.96 | 311,674 |
| 2021-04-05 | Silcock Raymond (EVP, Chief Financial Officer) | Option Ex | 3,964 | 40.39 | 160,105 |
Insider trading activities including stock purchases, stock sales, and option exercises of PRGO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Perrigo Co Plc (symbol PRGO, CIK number 1585364) see the Securities and Exchange Commission (SEC) website.